5819 completed, 1837 recruiting, 1687 unknown, 1412 terminated. 5154 Phase 2, 3717 Phase 1, 1657 Not applicable, 1101 Phase 3, 282 Phase 4.
Follow Lymphatic Diseases: new trials by email Literature Review of Lymphatic Diseases trials Research Report on Lymphatic Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FLASH Pilot Phase 1 Safety Study IntraOp Mobetron UHDR, Linac - Cutaneous Lymphoma | Not applicable | Not yet recruiting | Lesley A. Jarvis | 10 | 2029-10-31 | 2026-05-27 |
| A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia Blinatumomab, HyperCVAD - Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukemia | Phase 3 | Not yet recruiting | Amgen | 560 | 2028-06-30 | 2026-09-15 |
| Pyronaridine in Acute Myeloid Leukemia (AML) Pyronaridine Tetraphosphate - Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) | Phase 2 | Suspended | Armaceutica, Inc. | 200 | 2028-02-21 | 2026-10-19 |
| Family-Focused Study to Support Medication for Opioid Use Disorder FamilyCHESS, Standard of Care - Opioid Use Disorder, Opioid Use Disorder, Moderate | Not applicable | Not yet recruiting | University of Wisconsin, Madison | 338 | 2027-08-31 | 2026-07-07 |
| Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Phase 2 | Not yet recruiting | City of Hope Medical Center | 44 | 2027-08-04 | 2026-09-10 |
| Astragalus for Symptomatic Alleviation in High-grade Lymphoma Astragalus, Placebo - High-grade Lymphoma | Phase 3 | Not yet recruiting | Bnai Zion Medical Center | 60 | 2027-08-01 | 2026-09-30 |
| AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study") Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 1 | Recruiting | National Cancer Institute (NCI) | 15 | 2027-07-05 | 2026-10-28 |
| CAR-T Immunotherapy Targeting CD19- ALL 4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR - B-cell Leukemia | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 100 | 2027-07-01 | 2026-08-26 |
| VR-PAT and fNIRS to Identify CNS Biomarkers of Pain VR-PAT - Acute Pain, Pediatric ALL | Not applicable | Not yet recruiting | Nationwide Children's Hospital | 4 | 2027-07-01 | 2026-09-09 |
| Universal 4SCAR7U Targeting CD7-positive Malignancies Universal CD7-specific CAR gene-engineered T cells - T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma | Phase 1 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 30 | 2027-06-30 | 2026-08-26 |
| Multi-CAR-T Cells Targeting B Cell Lymphomas 4SCAR19 and 4SCAR20/22/70/PSMA/13/79b/GD2 - B Cell Lymphoma (BCL) | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 11 | 2027-06-01 | 2026-08-26 |
| Early Intervention Juzo Compression Sleeve and Glove, Compression Sleeve Sensor - Breast Cancer, Breast Cancer Treatment Related Lymphedema | Not applicable | Not yet recruiting | Massachusetts General Hospital | 40 | 2027-05-01 | 2026-07-13 |
| Prizloncabtagene Autoleucel (Prizlon-cel) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Post FDA Approved CAR T-cell Therapy Prizloncabtagene Autoleucel - Large B Cell Lymphoma, LBCL | Phase 2 | Not yet recruiting | AbelZeta Inc. | 55 | 2027-05-01 | 2026-10-15 |
| Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma | Phase 1 | Not yet recruiting | City of Hope Medical Center | 16 | 2027-04-17 | 2026-08-11 |
| Phase I Safety Clinical Trial of Anti-CD19 CAR-T Therapy COL01 for the Treatment of Adults With Relapsed or Refractory B-cell Lymphoid Neoplasms: First-in-human Administration, COLIBRI. CAR-T anti-CD19 COL01 - Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia, Lymphoid Malignancies | Phase 1 | Not yet recruiting | GUSTAVO SALGUERO | 12 | 2027-04-01 | 2026-10-20 |
| Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma Biospecimen Collection, Computed Tomography, Positron Emission Tomography - Recurrent Plasmablastic Lymphoma, Refractory Plasmablastic Lymphoma | Phase 1 | Recruiting | National Cancer Institute (NCI) | 30 | 2027-03-26 | 2026-10-20 |
| BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases. teclistamab OR talquetamab OR elranatamab OR linvoseltamab, BTK inhibitors (ibrutinib and zanubrutinib) - Waldenstrom Macroglobulinaemia, Multiple Myeloma | Phase 4 | Not yet recruiting | Anne Louise Tølbøll Sørensen | 400 | 2027-03-01 | 2026-03-16 |
| 2 Gy Total Body Irradiation As Part Of Conditioning Treatment For Patients With Acute Lymphoblastic Leukemia Undergoing CAR T Cell Therapy CAR T cell therapy - Acute Lymphoblastic Leukemia | Not applicable | Not yet recruiting | M.D. Anderson Cancer Center | 20 | 2027-03-01 | 2026-10-05 |
| Microbiome Intervention for CAR-T Optimization and Response (MICRO-CART) Live Biotherapeutic Product (LBP), Placebo - Lymphoma, B-Cell, Multiple Myeloma | Phase 1 | Not yet recruiting | University of Chicago | 32 | 2027-02-23 | 2026-10-22 |
| Teclistamab In Waldenstrom's Macroglobulinemia Teclistamab - Waldenstrom's Macroglobulinemia | Phase 2 | Not yet recruiting | Massachusetts General Hospital | 24 | 2027-02-19 | 2026-09-01 |
Showing 20 of 12799. Sign in to see all of them.
Lymphoma (3016) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2521) · Lymphoma, Non-Hodgkin (2288) · Leukemia, Lymphocytic, Chronic, B-Cell (2019) · Lymphoma, Follicular (1875) · Lymphoma, Large B-Cell, Diffuse (1825) · Leukemia (1370) · Hodgkin Disease (1301) · Lymphoma, Mantle-Cell (1210) · Leukemia, Myeloid, Acute (1017) · Burkitt Lymphoma (974) · Multiple Myeloma (895) · Recurrence (879) · Lymphoma, B-Cell, Marginal Zone (864) · Lymphoma, B-Cell (777)
Hemic and Lymphatic Diseases (12798) · Immune System Diseases (11512) · Lymphoproliferative Disorders (11347) · Neoplasms by Histologic Type (11255) · Immunoproliferative Disorders (11123) · Neoplasms (10979) · Hematologic Diseases (5448) · Lymphoma (5258) · Leukemia, Lymphoid (4252) · Lymphoma, Non-Hodgkin (4026) · Pathological Conditions, Signs and Symptoms (3925) · Pathologic Processes (3668) · Leukemia (3500) · Disease Attributes (3104)
Rituximab (1440) · Cyclophosphamide (1362) · Vincristine (680) · Doxorubicin (601) · Prednisone (548) · Etoposide (543) · Cytarabine (516) · fludarabine (488) · Methotrexate (464) · Dexamethasone (430) · fludarabine phosphate (411) · Lenalidomide (362) · Filgrastim (355) · Bendamustine Hydrochloride (288) · venetoclax (279)
National Cancer Institute (NCI) (567) · M.D. Anderson Cancer Center (420) · Memorial Sloan Kettering Cancer Center (229) · Fred Hutchinson Cancer Center (155) · City of Hope Medical Center (140) · Hoffmann-La Roche (126) · Novartis Pharmaceuticals (117) · Children's Oncology Group (114) · St. Jude Children's Research Hospital (113) · Dana-Farber Cancer Institute (112) · Ruijin Hospital (97) · Mayo Clinic (93) · Assistance Publique - Hôpitaux de Paris (87) · Institute of Hematology & Blood Diseases Hospital, China (84) · Celgene (81)
United States (6595) · China (1759) · France (1155) · Italy (970) · United Kingdom (825) · Germany (785) · Canada (783) · Spain (751) · Australia (589) · South Korea (452) · Belgium (440) · Poland (395) · Netherlands (383) · Denmark (317) · Japan (301)
PMID 34515338, PMID 41671463, PMID 35622074, PMID 40135712, PMID 32632956, PMID 32499241, PMID 34398557, PMID 31401903, PMID 40550489, PMID 38502198, PMID 39319495, PMID 39563886, PMID 26373676, PMID 37505794, PMID 38620092, PMID 23524640, PMID 27209293, PMID 27282998, PMID 31050355, PMID 33242441, PMID 34393061, PMID 39121442, PMID 40802906, PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 23065508, PMID 23834234, PMID 29358183, PMID 30125215, PMID 31196847, PMID 32816215, PMID 34048072, PMID 35787017, PMID 41429239, PMID 17284531, PMID 18596230, PMID 19238148, PMID 26182309, PMID 28054442, PMID 28751558, PMID 31023700, PMID 32770353, PMID 33288485, PMID 33883258, PMID 34608724, PMID 34780125, PMID 34865212
2023 (104), P30CA033572 (102), P30CA015704 (83), 2015 (66), 2016 (60), 2017 (57), 2018 (57), 2014 (50), U10CA032102 (50), 2009 (45), U10CA180820 (45), P30CA016672 (44), U10CA098543 (43), P30CA015083 (40), U10CA031946 (40)